Home Nucleus Healthcare Canada and U.S. Point Of Care Testing Market to 2032

Canada and U.S. Point Of Care Testing Market to 2032

Overview

The Canada and U.S. Point Of Care Testing Market is expected to reach a 31.72 USD Billion by 2032 and is projected to grow at a CAGR of 9.62% from 2025 to 2032.

Revenue, 2024 (USD Billion)
15.25
Forecast, 2032 (USD Billion)
31.72
CAGR, 2024 - 2032
9.62%
Report Coverage
North America

Canada and U.S. Point Of Care Testing Market 2018-2032 USD Billion

Canada and U.S. Point Of Care Testing Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 15.25 USD Billion
  • Projected Market Size (2032): 31.72 USD Billion
  • CAGR (2025-2032): 9.62%

Key Findings of Canada and U.S. Point Of Care Testing Market

  • The Canada and U.S. Point Of Care Testing Market was valued at 15.25 USD Billion in 2024.
  • The Canada and U.S. Point Of Care Testing Market is likely to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Laboratory based Point-of-Care-Testing (POCT) in Testing Location Segment accounted for the largest share of the market with a revenue of 9.18 USD Billion
  • The fastest growing segment Online Sales in Distribution Channel Segment grew Fastest with a CAGR of 10.21% during the forecast period from 2024 to 2032.

Canada and U.S. Point Of Care Testing Market Scope

Canada and U.S. Point Of Care Testing Market Segmentation & Scope
Method/Technology
  • Others
  • Microfluidics / Lab-on-a-Chip
  • LAMP (Loop-Mediated Isothermal Amplification)
  • NAAT (Nucleic Acid Amplification Tests)
Panel Type
  • Triplex Assay
  • Duplex Assay
  • Multiplex Panel (Syndromic Testing)
  • Simplex Assay
Distribution Channel
  • Others
  • Online Sales
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Elderly Care Centers
  • Ambulatory Surgery Centers
  • Laboratories
  • Clinics
  • Home Care
  • Hospitals
Testing Location
  • At-Home Point-of-Care-Testing (POCT)
  • Laboratory based Point-of-Care-Testing (POCT)
Product/Disease
  • Blood Yeast Infections (Fungal BSI)
  • Others
  • Bloodstream Infections (BSI)
  • Hepatitis
  • Sexually Transmitted Disease (STD)
  • Gastroenteric Infections
  • Respiratory Infections

Canada and U.S. Point Of Care Testing Market Data Coverage Insights

Study Period 2024-2032
Base Year 2024
Unit Revenue in USD Billion
Market Value in 2024 15.25 USD Billion
Market Value in 2032 31.72 USD Billion
CAGR (2025-2032) 9.62%
Historic Data 2016-2023
Market Segments Covered Method/Technology,Panel Type,Distribution Channel,End User,Testing Location,Product/Disease

Regional Insights:

  • Leading Market (2024-2032): North America, leading in terms of revenue 15.25 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 13,498.18 USD Million in 2024.

Segments and Scope

  • Canada and U.S. Point Of Care Testing Market to 2032, By Method/Technology
    • NAAT (Nucleic Acid Amplification Tests) is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 8.41 USD Billion in the year 2024.
    • LAMP (Loop-Mediated Isothermal Amplification) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.88 % in forecast period 2025-2032.
  • Canada and U.S. Point Of Care Testing Market to 2032, By Panel Type
    • Simplex Assay is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 8.01 USD Billion in the year 2024.
    • Multiplex Panel (Syndromic Testing) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.53 % in forecast period 2025-2032.
  • Canada and U.S. Point Of Care Testing Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 6.74 USD Billion in the year 2024.
    • Online Sales is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.30 % in forecast period 2025-2032.
  • Canada and U.S. Point Of Care Testing Market to 2032, By End User
    • Hospitals is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 6.53 USD Billion in the year 2024.
    • Home Care is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.83 % in forecast period 2025-2032.
  • Canada and U.S. Point Of Care Testing Market to 2032, By Testing Location
    • Laboratory based Point-of-Care-Testing (POCT) is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 9.18 USD Billion in the year 2024.
    • At-Home Point-of-Care-Testing (POCT) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.47 % in forecast period 2025-2032.
  • Canada and U.S. Point Of Care Testing Market to 2032, By Product/Disease
    • Respiratory Infections is the largest segment in Canada and U.S. Point Of Care Testing Market to 2032 with a revenue of 7.10 USD Billion in the year 2024.
    • Sexually Transmitted Disease (STD) is the Fastest growing segment in Canada and U.S. Point Of Care Testing Market to 2032 with a Growth rate of 9.73 % in forecast period 2025-2032.

Canada and U.S. Point Of Care Testing Market Company Share Analysis

 
Canada and U.S. Point Of Care Testing Market Company Share Analysis
Canada and U.S. Point Of Care Testing Market Company Share Analysis

Canada and U.S. Point Of Care Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

Canada and U.S. Point Of Care Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

Canada and U.S. Point Of Care Testing Market Company Profiling

Canada and U.S. Point Of Care Testing Market Company Profiling

Industry Related Reports

Global Discharge Inks Market for Textile Industry Market
Global Stem Cell Manufacturing Market
Global Affinity Membrane Chromatography Market
Global Internet of Medical Things Market
Global Drug Delivery Devices Market
Global Newborn Screening Market
Global Microfluidics Market
Global Prepacked Chromatography Columns Market
Global Skin Tightening Market
Global Injectable Drug Delivery Market
Frequently Asked Questions
The Canada and U.S. Point Of Care Testing Market is segmented based on Segmentation Method/Technology,Panel Type,Distribution Channel,End User,Testing Location,Product/Disease.
Canada and U.S. Point Of Care Testing Market was valued at USD 15.25(Revenue in USD Billion) in 2024.
Canada and U.S. Point Of Care Testing Market is projected to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
The Laboratory based Point-of-Care-Testing (POCT) segment is expected to dominate the Canada and U.S. Point Of Care Testing Market, holding a largest market share of 9.18 USD Billion in 2024

Coming Soon....

Canada and U.S. Point Of Care Testing Market Scope

Canada and U.S. Point Of Care Testing Market Segmentation & Scope
Method/Technology
  • Others
  • Microfluidics / Lab-on-a-Chip
  • LAMP (Loop-Mediated Isothermal Amplification)
  • NAAT (Nucleic Acid Amplification Tests)
Panel Type
  • Triplex Assay
  • Duplex Assay
  • Multiplex Panel (Syndromic Testing)
  • Simplex Assay
Distribution Channel
  • Others
  • Online Sales
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Elderly Care Centers
  • Ambulatory Surgery Centers
  • Laboratories
  • Clinics
  • Home Care
  • Hospitals
Testing Location
  • At-Home Point-of-Care-Testing (POCT)
  • Laboratory based Point-of-Care-Testing (POCT)
Product/Disease
  • Blood Yeast Infections (Fungal BSI)
  • Others
  • Bloodstream Infections (BSI)
  • Hepatitis
  • Sexually Transmitted Disease (STD)
  • Gastroenteric Infections
  • Respiratory Infections
Frequently Asked Questions
The Canada and U.S. Point Of Care Testing Market is segmented based on Segmentation Method/Technology,Panel Type,Distribution Channel,End User,Testing Location,Product/Disease.
Canada and U.S. Point Of Care Testing Market was valued at USD 15.25(Revenue in USD Billion) in 2024.
Canada and U.S. Point Of Care Testing Market is projected to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
The estimated market value of the Canada and U.S. Point Of Care Testing Market for final year is USD 31.72 (USD Billion).

Canada and U.S. Point Of Care Testing Market Company Profiling

Canada and U.S. Point Of Care Testing Market Company Profiling
Frequently Asked Questions
The Canada and U.S. Point Of Care Testing Market is segmented based on Segmentation Method/Technology,Panel Type,Distribution Channel,End User,Testing Location,Product/Disease.
Canada and U.S. Point Of Care Testing Market was valued at USD 15.25(Revenue in USD Billion) in 2024.
Canada and U.S. Point Of Care Testing Market is projected to grow at a CAGR of 9.62% during the forecast period of 2024 to 2032.
The estimated market value of the Canada and U.S. Point Of Care Testing Market for final year is USD 31.72 (USD Billion).

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.